We thank the MONOD ANRS 12206 trial independent data monitoring committee meeting: Dominique Costagliola (Chair Mark Cotton (Cape Town, Diana Gibb) and Elisabeth Menu Désiré Dahourou PhD was funded by the ANRS (ANRS12206-B89). Malik Coulibaly PhD was funded by EDCTP-ANRS-LIH ,
Programme National de Prise en Charge Community representatives, Pharmacie de la Santé Publique: Carine Kodo. Implementers: Touré Siaka, Pety Touré (ACONDA), Fassinou Ekouevi (EGPAF) Programme National de Santé Infantile: Dorothée Koumi. Programme Elargi de Vaccination: Berté Koné. Methodology and Data Management Center: Inserm U897 Carole Devaux ,
The content is solely the responsibility of the authors and does not necessarily represent the official views of the French Inserm-ANRS ,
Centre de Recherche Internationale pour la Santé ,
Côte d'Ivoire. 13 Paediatric Department 15 UMR 1058, Pathogenesis and control of chronic infections, Inserm, Inserm, issue.16, p.17 ,
ISBN 978-92-9253-062-4 Geneva: UNAIDS; 2014, pp.1-422, 2014. ,
Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis, The Lancet, vol.364, issue.9441, pp.1236-1279, 2004. ,
DOI : 10.1016/S0140-6736(04)17140-7
Early Antiretroviral Therapy and Mortality among HIV-Infected Infants, New England Journal of Medicine, vol.359, issue.21, pp.2233-2277, 2008. ,
DOI : 10.1056/NEJMoa0800971
Antiretroviral Treatment for Children with Peripartum Nevirapine Exposure, New England Journal of Medicine, vol.363, issue.16, pp.1510-1530, 2010. ,
DOI : 10.1056/NEJMoa1000931
Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children, New England Journal of Medicine, vol.366, issue.25, pp.2380-2389, 2012. ,
DOI : 10.1056/NEJMoa1113249
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443859
Rapport du Groupe d'Experts 2008 sur la prise en charge médicale des patients infectées par le VIH, sous la direction du Pr Patrick Yeni, p.409, 2008. ,
Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age, AIDS, vol.29, issue.10, pp.1247-59, 2015. ,
DOI : 10.1097/QAD.0000000000000672
Instability of lopinavir/ritonavir capsules at ambient temperatures in sub-Saharan Africa: relevance to WHO antiretroviral guidelines, AIDS, vol.19, issue.11, pp.1233-1237, 2005. ,
DOI : 10.1097/01.aids.0000176227.01850.9e
Effect of Rifampicin on Lopinavir Pharmacokinetics in HIV-Infected Children With Tuberculosis, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.47, issue.5, pp.566-575, 2008. ,
DOI : 10.1097/QAI.0b013e3181642257
Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz, Pediatric Health Med Ther, vol.5, pp.29-42, 2014. ,
Is the Recommended Dose of Efavirenz Optimal in Young West African Human Immunodeficiency Virus-Infected Children?, Antimicrobial Agents and Chemotherapy, vol.53, issue.10, pp.4407-4420, 2009. ,
DOI : 10.1128/AAC.01594-08
Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting, Journal of Clinical Microbiology, vol.43, issue.6, pp.2709-2726, 2005. ,
DOI : 10.1128/JCM.43.6.2709-2717.2005
Reporting of Noninferiority and Equivalence Randomized Trials, JAMA, vol.308, issue.24, pp.2594-604, 2012. ,
DOI : 10.1001/jama.2012.87802
Trials to assess equivalence: the importance of rigorous methods, BMJ, vol.313, issue.7048, pp.36-45, 1996. ,
DOI : 10.1136/bmj.313.7048.36
Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, J Int AIDS Soc, vol.19, issue.1, p.20601, 2011. ,
Virological response and resistances over 12 months among HIV?infected children less than 2 years receiving first-line lopinavir /ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort, J Int AIDS Soc, 2017. ,
Reuse of Nevirapine in Exposed HIV-Infected Children After Protease Inhibitor???Based Viral Suppression, JAMA, vol.304, issue.10, pp.1082-90, 2010. ,
DOI : 10.1001/jama.2010.1278
Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa, JAMA, vol.314, issue.17, pp.1808-1825, 2015. ,
DOI : 10.1001/jama.2015.13631
Rethinking the risk???benefit ratio of efavirenz in HIV-infected children, The Lancet Infectious Diseases, vol.16, issue.5, pp.76-81, 2016. ,
DOI : 10.1016/S1473-3099(16)00117-1
Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis, International Journal of Epidemiology, vol.36, issue.5, pp.1009-1030, 2007. ,
DOI : 10.1093/ije/dym104
URL : https://hal.archives-ouvertes.fr/inserm-00187308
Initiation of Antiretroviral Treatment in Women After Delivery Can Induce Multiclass Drug Resistance in Breastfeeding HIV-Infected Infants, Clinical Infectious Diseases, vol.52, issue.8, pp.1069-76, 2011. ,
DOI : 10.1093/cid/cir008
HIV-1 Drug Resistance Emergence among Breastfeeding Infants Born to HIV-Infected Mothers during a Single-Arm Trial of Triple-Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission: A Secondary Analysis, PLoS Medicine, vol.20, issue.3, p.1000430, 2011. ,
DOI : 10.1371/journal.pmed.1000430.s001
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial, Lancet Infect Dis, vol.11, issue.4, pp.273-83, 2011. ,
Missed Opportunities for Early Access to Care of HIV-Infected Infants in Burkina Faso, PLoS ONE, vol.346, issue.10, p.111240, 2014. ,
DOI : 10.1371/journal.pone.0111240.s001
Access to early infant diagnosis and antiretroviral therapy in Abidjan, Côte d'Ivoire, 21st Conference on Retroviruses and Opportunistic Infections, pp.2011-2013, 2014. ,
Early infant diagnosis of HIV infection in low-income and middle-income countries: does one size fit all?, The Lancet Infectious Diseases, vol.14, issue.7, pp.650-655, 2014. ,
DOI : 10.1016/S1473-3099(13)70262-7
Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions, BMC Medicine, vol.336, issue.Suppl 1, p.59, 2011. ,
DOI : 10.1056/NEJM199705083361901
URL : https://hal.archives-ouvertes.fr/inserm-00605913
Universal HIV Screening at Postnatal Points of Care: Which Public Health Approach for Early Infant Diagnosis in C??te d'Ivoire?, PLoS ONE, vol.28, issue.8, p.67996, 2013. ,
DOI : 10.1371/journal.pone.0067996.t003
Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years, AIDS, vol.29, issue.13, pp.1623-1655, 2015. ,
DOI : 10.1097/QAD.0000000000000749
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833198
Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children, Antiviral Therapy, vol.21, issue.7, pp.579-85, 2016. ,
DOI : 10.3851/IMP3054
Use of Integrase Inhibitors in HIV-Infected Children and Adolescents, Drugs, vol.68, issue.3, pp.1483-97, 2015. ,
DOI : 10.1007/s40265-015-0446-2